clopidogrel has been researched along with Kidney Failure, Chronic in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (22.22) | 29.6817 |
2010's | 23 (63.89) | 24.3611 |
2020's | 5 (13.89) | 2.80 |
Authors | Studies |
---|---|
Chan, YH; Chang, CJ; Chang, SH; Kuo, CT; Liu, JR; See, LC; Tung, YC | 1 |
Al-Hindi, L; Dai, J; Hedayati, SS; Jain, N; Martin, BC; Mehta, JL; Phadnis, MA; Rasu, RS; Shireman, TI | 1 |
Antono, D; Nugroho, P; Rinaldi, I; Rusdi, L; Shatri, H; Wahyudi, W; Wijaya, IP; Yunir, E | 1 |
Cui, H; Dai, J; Hunt, SL; Jain, N; Mahnken, JD; Mehta, JL; Phadnis, MA; Rasu, RS; Shireman, TI | 1 |
Wiśniewski, A | 1 |
Beasley, M; Brown, TM; Cai, A; Clarkson, SA; Dillon, C; Heindl, B; Limdi, N | 1 |
Ihm, CG; Jeong, KH; Kim, JB; Kim, JS; Kim, KS; Kim, W; Kim, WS; Lee, TW; Woo, JS | 1 |
Bonello, L; Burtey, S; Laine, M; Lemesle, G; Puymirat, E | 1 |
Açıl, T; Doğan, A; Kahraman, S; Kurtoğlu, N; Özdemir, E; Saltan, Y | 1 |
Ariyoshi, N; Fujii, K; Fujimoto, Y; Kitahara, H; Kobayashi, Y; Kohno, Y; Nishi, T; Ohno, Y | 1 |
Cao, L; Gui, K; Li, N; Wan, Z; Wang, Q; Xiong, M; Yan, W; Yang, C; Yang, R; Zhang, Y; Zhao, M; Zhu, Y | 1 |
Chang, TY; Fan, PY; Hsieh, MY; Kuo, CF; Lee, CC; Li, IJ; Liu, SH; Tian, YC; Tu, KH; Weng, CH; Wu, HH; Yang, CW | 1 |
Du, L; Du, X; Lai, J; Lai, Q; Tu, B; Wan, Z; Xu, B; Zhang, F; Zhao, M; Zhou, Y | 1 |
Cheng, CI; Chung, WJ; Hsueh, SK; Lee, CH; Lin, CJ; Tsai, TH | 1 |
Abramowicz, D; Benahmed, A; Broeders, N; Donckier, V; Ghisdal, L; Hoang, AD; Kianda, M; Le Moine, A; Lemy, A; Madhoun, P; Massart, A; Mikhalski, D; Racapé, J; Sadis, C; Wissing, M | 1 |
Bocksch, W; Fateh-Moghadam, S; Gawaz, M; Geisler, T; Htun, P; Kan, T; Mueller, E; Pohle, C; Schindler, R | 1 |
Chen, CY; Huang, YB; Lai, WT; Lee, CT; Lee, KT | 1 |
Antonopoulos, C; Kakisis, JD; Liapis, CD; Moulakakis, K; Sfyroeras, G; Vassilas, K | 1 |
Blicher, TM; Hommel, K; Kamper, AL; Kristensen, SL; Madsen, M; Olesen, JB; Torp-Pedersen, C | 1 |
Axelrod, D; Dzebisashvili, N; Lentine, KL; Mogal, H; Schnitzler, M; Tuttle-Newhall, JE; Williams, JM; Xiao, H | 1 |
Cho, JH; Ihm, CG; Jeong, KH; Kim, JB; Kim, KS; Kim, W; Kim, WS; Lee, TW; Woo, JS | 1 |
Bouatou, Y; Daali, Y; Desmeules, J; Fontana, P; Samer, CF | 1 |
Chao, PW; Chen, HT; Chen, YT; Hsu, CY; Kuo, SC; Ou, SM; Shih, CJ | 1 |
Chan, KE; Hakim, RM; Lazarus, JM; Thadhani, R | 1 |
Kittisupamongkol, W | 1 |
Hwang, SH; Kang, WY; Kim, W; Park, CS; Park, SH | 1 |
Fareed, J; Jeske, WP; Mousa, SA | 1 |
Jakubowski, JA; Li, YG; Luo, J; Payne, CD; Small, DS; Tomlin, ME; Winters, KJ | 1 |
Anker, SD; Ponikowski, P; Ronco, C | 1 |
Abi Rached, J; Ayoub, I; El-Sayegh, S; Geara, AS; Ghimire, P; Siddique, MN | 1 |
Alexopoulos, D; Goudas, P; Goumenos, D; Koutroulia, E; Plakomyti, TE; Xanthopoulou, I | 1 |
Cronin, RE; Fiore, LD; Ganz, MB; Goldfarb, DS; Kaufman, JS; O'Connor, TZ; Peduzzi, PN; Zhang, JH | 1 |
Agca, E; Akcay, A; Kanbay, M; Ozdemir, FN; Sezer, S | 1 |
Kim, JW; Oh, DJ; Park, CG; Rha, SW; Ro, YM; Seo, HS; Suh, SY | 1 |
Beyar, R; Gruberg, L | 1 |
Hawken, S; Keltai, M; Lewis, BS; Mann, JF; Mehta, SR; Sitkei, E; Tonelli, M; Yusuf, S | 1 |
5 review(s) available for clopidogrel and Kidney Failure, Chronic
Article | Year |
---|---|
Efficacy and Safety of Clopidogrel in the Prevention of Primary Failure of Arteriovenous Fistula in Patients with End-Stage Renal Disease: A Systematic Review.
Topics: Arteriovenous Fistula; Arteriovenous Shunt, Surgical; Clopidogrel; Hemorrhage; Humans; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renal Dialysis | 2023 |
Multifactorial Background for a Low Biological Response to Antiplatelet Agents Used in Stroke Prevention.
Topics: Aspirin; Biological Availability; Clopidogrel; Drug Interactions; Drug Resistance; Humans; Ischemic Stroke; Kidney Failure, Chronic; Metabolic Syndrome; Pharmacogenomic Variants; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Assessment; Secondary Prevention; Smoking; Stroke | 2021 |
Wandering stent within the pulmonary circulation.
Topics: Aged, 80 and over; Angiography, Digital Subtraction; Anticoagulants; Arteriovenous Shunt, Surgical; Blood Vessel Prosthesis Implantation; Catheterization, Central Venous; Clopidogrel; Endovascular Procedures; Foreign-Body Migration; Graft Occlusion, Vascular; Heparin, Low-Molecular-Weight; Humans; Kidney Failure, Chronic; Male; Platelet Aggregation Inhibitors; Pulmonary Artery; Renal Dialysis; Stents; Ticlopidine; Treatment Outcome; Upper Extremity | 2014 |
Evidence-Based Choice of P2Y12 Inhibitors in End Stage Renal Disease Patients: A Mini-Review.
Topics: Adenosine; Animals; Cardiovascular Diseases; Clopidogrel; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine | 2015 |
Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.
Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Aspirin; Clinical Trials, Phase III as Topic; Clopidogrel; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hemorrhage; Humans; Ischemia; Kidney Failure, Chronic; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2 Receptor Antagonists; Randomized Controlled Trials as Topic; Receptors, Purinergic P2Y12; Thiophenes; Ticlopidine | 2010 |
5 trial(s) available for clopidogrel and Kidney Failure, Chronic
Article | Year |
---|---|
The pharmacodynamics of low and standard doses of ticagrelor in patients with end stage renal disease on hemodialysis.
Topics: Adenosine; Adult; Aged; Clopidogrel; Dose-Response Relationship, Drug; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Renal Dialysis; Ticagrelor; Ticlopidine | 2017 |
Platelet reactivity after receiving clopidogrel compared with ticagrelor in patients with kidney failure treated with hemodialysis: a randomized crossover study.
Topics: Adenosine; Adult; Aspirin; Clopidogrel; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Renal Dialysis; Single-Blind Method; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome | 2015 |
A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure.
Topics: Analysis of Variance; Clopidogrel; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Single-Blind Method; Ticlopidine | 2009 |
Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.
Topics: Aged; Aspirin; Catheters, Indwelling; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Polytetrafluoroethylene; Renal Dialysis; Thrombosis; Ticlopidine | 2003 |
Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
Topics: Aged; Angina, Unstable; Clopidogrel; Coronary Disease; Creatinine; Double-Blind Method; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Research Design; Risk Factors; Severity of Illness Index; Survival Analysis; Syndrome; Ticlopidine; Treatment Outcome | 2007 |
26 other study(ies) available for clopidogrel and Kidney Failure, Chronic
Article | Year |
---|---|
Outcomes after ticagrelor versus clopidogrel treatment in end-stage renal disease patients with acute myocardial infarction: a nationwide cohort study.
Topics: Aged; Clopidogrel; Cohort Studies; Female; Humans; Kidney Failure, Chronic; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Renal Dialysis; Ticagrelor; Treatment Outcome | 2021 |
Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y
Topics: Aged; Clopidogrel; Gastrointestinal Hemorrhage; Humans; Kidney Failure, Chronic; Middle Aged; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Renal Dialysis; Retrospective Studies; Ticagrelor | 2022 |
Trends for and Clinical Factors Associated with Choice of Oral P2Y
Topics: Administration, Oral; Adolescent; Adult; Aged; Cardiovascular Diseases; Clinical Decision-Making; Clopidogrel; Drug Prescriptions; Drug Utilization; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Patient Selection; Peritoneal Dialysis; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Prevalence; Purinergic P2Y Receptor Antagonists; Registries; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; United States; Young Adult | 2019 |
Outcomes of Individuals With and Without Heart Failure Presenting With Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Aspirin; Case-Control Studies; Clopidogrel; Diabetes Mellitus; Dual Anti-Platelet Therapy; Female; Heart Failure; Hemorrhage; Hospitalization; Humans; Ischemic Attack, Transient; Ischemic Stroke; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Infarction; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Proportional Hazards Models; Risk Factors; ST Elevation Myocardial Infarction; Stroke Volume; Ticagrelor; Treatment Outcome | 2021 |
Research and Therapeutic Nihilisms in Chronic Kidney Disease.
Topics: Acute Coronary Syndrome; Clopidogrel; Humans; Kidney Failure, Chronic; Percutaneous Coronary Intervention; Prasugrel Hydrochloride; Renal Insufficiency, Chronic | 2017 |
Impact of early (3 months) dual antiplatelet treatment interruption prior to renal transplantation in patients with second-generation DES on perioperative stent thrombosis and MACEs.
Topics: Clopidogrel; Drug Administration Schedule; Drug-Eluting Stents; Everolimus; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Preoperative Period; Retrospective Studies; Sirolimus; Thrombosis | 2017 |
High residual platelet reactivity after switching from clopidogrel to low-dose prasugrel in Japanese patients with end-stage renal disease on hemodialysis.
Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Drug Substitution; Female; Humans; Japan; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Prospective Studies; Renal Dialysis | 2019 |
Beraprost sodium versus clopidogrel for preventing vascular thromboembolic events of arteriovenous fistula in uraemic patients: a retrospective study with a mean 3-year follow-up.
Topics: Administration, Oral; Adult; Arteriovenous Fistula; Clopidogrel; Drug Administration Schedule; Epoprostenol; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Dialysis; Retrospective Studies; Uremia; Venous Thromboembolism | 2019 |
Preventing arteriovenous shunt failure in hemodialysis patients: a population-based cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arteriovenous Shunt, Surgical; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Vessel Prosthesis Implantation; Clopidogrel; Databases, Factual; Female; Gastrointestinal Hemorrhage; Graft Occlusion, Vascular; Humans; Intracranial Hemorrhages; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Taiwan; Thrombosis; Treatment Failure; Warfarin; Young Adult | 2019 |
Comparing the vascular thromboembolic events following arteriovenous fistula in Chinese population with end-stage renal diseases receiving Clopidogrel versus Beraprost sodium therapy: a retrospective cohort study.
Topics: Adult; Aged; Arteriovenous Shunt, Surgical; China; Clopidogrel; Constriction, Pathologic; Epoprostenol; Female; Hemorrhage; Humans; Incidence; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Renal Dialysis; Retrospective Studies; Thrombosis; Time Factors; Young Adult | 2018 |
Efficacy and Safety of Ticagrelor Compared with Clopidogrel in Patients with End-Stage Renal Disease with Acute Myocardial Infarction.
Topics: Aged; Clopidogrel; Female; Hemorrhage; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Ticagrelor; Treatment Outcome | 2019 |
Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study.
Topics: Aspirin; Blood Loss, Surgical; Case-Control Studies; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Incidence; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Prognosis; Retrospective Studies; Risk; Risk Factors; Survival Rate; Ticlopidine; Time Factors | 2014 |
Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease. Results of a pilot study.
Topics: Aged; Aspirin; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Receptors, Purinergic P2Y12; Renal Dialysis; Risk; Ticlopidine | 2014 |
Effectiveness and safety of antiplatelet in stroke patients with end-stage renal disease undergoing dialysis.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Platelet Aggregation Inhibitors; Recurrence; Renal Dialysis; Retrospective Studies; Stroke; Ticlopidine; Treatment Outcome | 2014 |
Benefit of clopidogrel therapy in patients with myocardial infarction and chronic kidney disease-a Danish nation-wide cohort study.
Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Case-Control Studies; Clopidogrel; Cohort Studies; Data Collection; Denmark; Female; Hemorrhage; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Recurrence; Renal Dialysis; Renal Insufficiency, Chronic; Ticlopidine; Treatment Outcome | 2014 |
Clopidogrel use as a risk factor for poor outcomes after kidney transplantation.
Topics: Cardiovascular Diseases; Clopidogrel; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Period; Prognosis; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Survival Rate; Ticlopidine; Tissue Donors; Transplantation, Homologous; United States | 2014 |
Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.
Topics: Aged; Aspirin; Brain Ischemia; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Propensity Score; Renal Dialysis; Retrospective Studies; Stroke; Survival Rate; Taiwan; Ticlopidine | 2017 |
Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.
Topics: Aged; Anticoagulants; Clopidogrel; Cohort Studies; Confidence Intervals; Female; Humans; International Normalized Ratio; Kidney Failure, Chronic; Longitudinal Studies; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Racial Groups; Renal Dialysis; Retrospective Studies; Risk Assessment; Ticlopidine; Warfarin | 2009 |
Clopidogrel in ESRD patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aspirin; Clopidogrel; Hemorrhage; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Ticlopidine | 2009 |
A comparison of the VerifyNow P2Y12 point-of-care device and light transmission aggregometry to monitor platelet function with prasugrel and clopidogrel: an integrated analysis.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Adult; Aged; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Databases, Factual; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Piperazines; Platelet Aggregation Inhibitors; Platelet Function Tests; Point-of-Care Systems; Prasugrel Hydrochloride; Thiophenes; Ticlopidine | 2010 |
Cardiorenal syndromes--recommendations from clinical practice guidelines: the cardiologist's view.
Topics: Acute Disease; Acute Kidney Injury; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Chronic Disease; Clopidogrel; Heart Failure; Humans; Kidney Failure, Chronic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Renal Insufficiency; Shock, Cardiogenic; Stroke Volume; Syndrome; Ticlopidine | 2010 |
Does hemodialysis affect clopidogrel resistance as measured by VerifyNow P2Y12 test?
Topics: Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Drug Resistance; Humans; Kidney Failure, Chronic; Long-Term Care; Platelet Aggregation Inhibitors; Platelet Function Tests; Postoperative Complications; Predictive Value of Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Renal Dialysis; Stents; Ticlopidine; Treatment Outcome | 2011 |
Ticagrelor in clopidogrel-resistant patients undergoing maintenance hemodialysis.
Topics: Adenosine; Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Drug Resistance; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Purinergic P2Y Receptor Antagonists; Renal Dialysis; Ticagrelor; Ticlopidine | 2012 |
Neutropenia due to clopidogrel in a patient with end-stage renal disease.
Topics: Adult; Clopidogrel; Humans; Kidney Failure, Chronic; Male; Neutropenia; Platelet Aggregation Inhibitors; Renal Dialysis; Ticlopidine | 2004 |
Neutropenia associated with clopidogrel use in a patient with chronic renal failure who underwent percutaneous coronary and peripheral intervention.
Topics: Adult; Angioplasty, Balloon; Angioplasty, Balloon, Coronary; Clopidogrel; Fatal Outcome; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Kidney Failure, Chronic; Leukocyte Count; Neutropenia; Peritoneal Dialysis; Platelet Aggregation Inhibitors; Ticlopidine | 2006 |
End-stage renal disease and drug-eluting stents: one small step forward.
Topics: Angioplasty, Balloon, Coronary; Cardiovascular Diseases; Clopidogrel; Coronary Restenosis; Humans; Infusion Pumps, Implantable; Kidney Failure, Chronic; Myocardial Infarction; Myocardial Revascularization; Platelet Aggregation Inhibitors; Prevalence; Renal Dialysis; Stents; Ticlopidine; Treatment Outcome | 2006 |